Phase Zero
Individuals learn about the Halfway Home, the expectations of this level of care, and most importantly, their own identity.
Phase One
Individuals learn the necessary behaviors & responsibilities to productively re-enter society & become an active member of the local community.
Phase Two
Individuals begin job searching & prepare for entry into the workforce with the goal of understanding the responsibilities that aid in supporting recovery.
Phase Three
Individuals learn relapse prevention & how to balance responsibilities as they prepare to transition into a less structured treatment regime.
Residential Support
Allentown Halfway Home
24 S. 5th Street
Allentown, PA 18101
​
Phone: 610-439-0218
Fax: 610-439-8713
Email: halfwayhome@treatmenttrends.org
Admissions: jessicadecker@treatmenttrends.org
Not sure how to make a referral?
To view ste-by-step instructions, click here.
The treatment provided at Allentown Halfway Home reflects the ASAM criteria and DDAP designation for Level 3.1 clinically managed low intensity residential services.
​
TTI Allentown Halfway Home is a co-ed, 40-bed, state licensed and regulated, community-based drug and alcohol treatment facility for individuals over the age of eighteen. The facility is professionally staffed and managed in a supportive environment.
The programming within the facility emphasizes independent growth, citizenship and responsible community living. These services help to reintegrate residents into the community. The programming is designed to assist individuals in developing self-sufficiency through counseling services, vocational development, and other related services.
Allentown Halfway Home is fully licensed by the Department of Health as an inpatient, non-hospital, residential program and maintains contracts with various entities throughout Pennsylvania to serve those in need of support.
​
We offer multiple forms of MAT, including: oral naltrexone, extended release naltrexone (Vivitrol), extended release buprenorphine (Sublocade) and buprenorphine-naloxone products (such as Suboxone and Zubsolv).